Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, shared on X:
“So excited that United Arab Emirates (UAE) Emirates Drug Establishment (EDE) took the lead to approve the broadest indication to date for both non-muscle invasive bladder cancer in patients who had failed BCG therapy and for metastatic non-small cell lung cancer in patients who failed chemotherapy and checkpoint inhibitors.
The power of NK cells.”
We would also like to wish Dr. Patrick Soon-Shiong a Happy Birthday!
You can read:
NCCN Adds ImmunityBio’s Anktiva to Bladder Cancer Guidelines
Patrick Soon-Shiong is also the Executive Chairman at ImmunityBio and and Executive Chairman of the Los Angeles Times.